Centre Henri Becquerel
Rouen, 76000, France
NCT Number: NCT02515084
The purpose of the study is to evaluate the concordance between the 18F-PET/CT under thyrotropin stimulation and the diffusion-weighted Magnetic Resonance Imaging, in the detection of residual mass in 40 patients with partial response or relapsed differentiated thyroid carcinoma.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Rouen, 76000, France
The schedule and the procedures of the study are the following ones :
18F-FDG PET/CT DW-MRI of the neck if possible performed shortly after the PET CT or within following days
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A FDG PET scan and a diffusion-weighted Magnetic Resonance Imaging will be performed to compare the efficacy to diagnose relapse in thyroid carcinoma
Time frame: 1 year
To assess concordance between FDG PET-CT scan and MRI in detection of cervical residual masses in 40 patients in Partial Response or in relapse cervical well-differentiated thyroid carcinoma
Centre Henri Becquerel
Other
Preliminary Study of the Interest of Diffusion-weighted Magnetic Resonance Imaging in the Early Detection of Differentiated Thyroid Carcinoma Cervical Recurrence. Comparison with18F-FDG PET/CT
Acronym: THYRIRMTEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03483337
Disease Attributes, Endocrine Gland Neoplasms
New York, United States
View Trial DetailsNCT06087068
Disease Attributes, Endocrine Gland Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT06082180
Disease Attributes, Endocrine Gland Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT01833650
Endocrine Gland Neoplasms, Endocrine System Diseases
Nicosia, Cyprus
View Trial Details